Stock FARN FARON PHARMACEUTICALS OY
Add to a list
To use this feature you must be a member
Log inSign up

Consensus Faron Pharmaceuticals Oy

Equities

FARN

FI4000153309

Market Closed - London S.E.
Other stock markets
 11:35:21 2024-05-31 am EDT 		5-day change 1st Jan Change
185 GBX +4.23% Intraday chart for Faron Pharmaceuticals Oy -3.90% -39.34%
May. 22 Transcript : Faron Pharmaceuticals Oy - Special Call
May. 20 Faron Pharmaceuticals’ Blood Cancer Combo Shows Efficacy in Mid-stage Study MT

Evolution of the average Target Price on Faron Pharmaceuticals Oy

Price target over the last 5 years

History of analyst recommendation changes

6241d539eb1a7ae525adc.lOOxh2MzBYPWkp-fzi_kZ5GmAebokdD1rrM34SkLWIA.ppPA4zoKTMa9v8X19mKVBf_KVquw1YW6-vpmlh0zNfSnsd7_NkJKurjKxg~1f87e379c97eac4465b084c14cf5a355

Analyst Recommendations on Faron Pharmaceuticals Oy

Faron Pharmaceuticals Reports 100% Response Rate in Phase 1 Trial of Myeloid Leukemia Combo Drug MT
Faron Pharmaceuticals' Bexmarilimab shows 50% remission rate AN
Faron Halts Investigational COVID-19 Therapy Trial Due to Low Infection, Hospitalization Rates MT
Faron Closes HIBISCUS Trial Due to Low COVID-19 Infection and Hospitalization Rates in the US and Reverts Resources to the Development of Bexmarilimab CI
More recommendations

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
1
Last Close Price
2.171 EUR
Average target price
11.69 EUR
Spread / Average Target
+438.44%
High Price Target
11.69 EUR
Spread / Highest target
+438.44%
Low Price Target
11.69 EUR
Spread / Lowest Target
+438.44%

Consensus detail

Consensus revision (last 18 months)

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar
  1. Stock Market
  2. Equities
  3. FARN Stock
  4. Consensus Faron Pharmaceuticals Oy